Grady County, Georgia Legal Access to 16,590mg THCa Rick Simpson Oil: 553mg/mL 7-Cannabinoid RSO from Houston’s ABC13-Featured OilWell Cannabis—Patient-Controlled 1,500mg THCa-to-1,405mg THC Potency, Bentley’s 10-Year Miracle Legacy, Farm Bill Compliant Nationwide Shipping

Rick Simpson Oil (RSO) in Grady County, Georgia: The Complete Guide by OilWell Cannabis

Here in Grady County, where the agricultural roots run deep and neighbors still help neighbors, we understand the weight of hard decisions. When conventional medicine reaches its limits—whether you’re in Cairo, Whigham, or out in the farmlands between—you start searching for answers that actually fit your life. That’s where Rick Simpson Oil comes into the conversation.

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical professional. He was a power engineer and maintenance worker—a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and a constellation of post-concussion symptoms that conventional medicine could not adequately resolve. According to Simpson, the medications he was prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed by his doctor as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed.

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement around concentrated cannabis oil.

The crusade—spreading the oil

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil. Operating out of his property in Maccan, Nova Scotia, he began making the oil in large quantities and giving it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and others.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented Simpson’s claims, showed testimonials from people he had treated, and framed his work as a grassroots challenge to pharmaceutical and governmental interests. It was distributed freely online and became one of the most widely shared cannabis advocacy films of its era. Within cannabis communities, it was foundational—for many people, Run From The Cure was their introduction to the concept of concentrated cannabis oil as medicine.

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005, seizing plants and equipment. He was charged with cannabis cultivation, possession, and trafficking. Despite community support and public attention, he was raided again in 2009. He was acquitted on some charges but convicted on others. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, a book detailing his personal experience, his oil-making process, and his broader philosophical views on cannabis, medicine, and institutional suppression. He also maintained phoenixtears.ca as his primary online platform for information and advocacy.

Throughout his public career, Simpson’s position remained consistent and uncompromising: he maintained that cannabis oil—particularly high-THC oil made according to his specific method—could cure cancer and many other diseases, and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect their financial interests. He framed his work not merely as health advocacy but as a fight against institutional corruption.

What is traditional Rick Simpson Oil—the product

Traditional RSO refers to the specific type of concentrated cannabis oil that Simpson made and advocated for. It was defined not by lab specifications or regulatory standards but by his method and materials.

Source material: Simpson used high-THC, indica-dominant cannabis strains. He specifically favored heavy, sedating indica genetics and generally recommended against sativa-dominant strains for cancer treatment, believing that indica strains produced better therapeutic outcomes. He grew his own cannabis or sourced it from growers he trusted. There was no strain standardization—the starting material varied by availability and growing season.

Extraction solvent: Simpson originally used naphtha—a petroleum-based solvent commercially available as lighter fluid, Varsol, or similar products. He later also endorsed 99 percent isopropyl alcohol as an acceptable alternative. He explicitly warned against using other solvents, including butane or acetone, due to safety and purity concerns. Neither naphtha nor isopropyl alcohol is a food-grade solvent.

Extraction process:

1. Dry or semi-dry cannabis plant material was placed in a container (typically a bucket).
2. The material was covered with solvent and agitated or stirred for several minutes to dissolve cannabinoids.
3. The solvent was poured off through a filter into a separate collection vessel.
4. The process was repeated a second time with fresh solvent.
5. The combined solvent washes were placed in a rice cooker.
6. The solvent was evaporated at relatively low heat.
7. As the solvent evaporated, a thick, dark oil remained.
8. The final oil was transferred into oral syringes for storage and dosing.

Appearance: Traditional RSO was an extremely dark—nearly black—thick, viscous, tar-like oil with a strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: Primarily decarboxylated delta-9 THC (60-90% estimated), with naturally occurring minor cannabinoids at uncontrolled ratios. No standardization.

Terpene content: Minimal to none. The combination of solvent extraction and high-heat evaporation stripped traditional RSO of its terpene content.

Standardization and testing: None. Every batch was different because it depended entirely on starting material, growing conditions, solvent purity, extraction technique, and the individual maker’s process.

Residual solvent risk: Naphtha and isopropyl alcohol are not food-grade solvents. Naphtha may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves potentially harmful residues in the finished oil.

Simpson’s claims vs. the evidence record

Rick Simpson made expansive therapeutic claims about his oil. He stated that RSO could cure cancer and many other diseases. He was adamant, consistent, and public about these claims throughout his advocacy career.

What the preclinical literature shows: In vitro studies have demonstrated that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal model studies have shown some tumor-growth inhibition. These findings have generated legitimate scientific interest and ongoing research.

What the preclinical literature does not show: These findings have not translated into proven human cancer cures. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.

Institutional positions:

• The U.S. National Cancer Institute acknowledges that cannabinoids have been studied for potential anticancer effects but does not endorse cannabis or cannabis oil as a cancer treatment.
• The FDA has not approved any cannabis plant product for the treatment of cancer.
• Health Canada has never approved RSO or cannabis oil as a cancer cure.
• NCCIH explicitly states that the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea, and appetite-related indications—not cancer cure.

What Simpson got right: Simpson drew attention to cannabinoids as a serious area of biomedical research at a time when most of the world was ignoring it. His advocacy helped create the political, cultural, and social conditions for the legal cannabis industry that exists today.

What he overstated: The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it is not supported now. Encouraging patients to rely on RSO as a primary treatment in place of proven oncologic therapies carries genuine harm potential.

The OilWell Cannabis Story: From Bentley to Grady County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But the story that matters to Grady County residents starts with a dog named Bentley.

Bentley was more than just a pet—he was family. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said the pain medications would destroy his internal organs, causing him more pain and suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon the healing properties of CBD—through a question that changed everything. A kind-hearted rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience—but it was recreational. He had never explored the therapeutic and medicinal applications. Jessica’s question exposed a blind spot that would become a mission.

Determined to save Bentley, Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It was not a cure, but it was a lifeline. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect—dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those ten years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone could not address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat that is notoriously difficult and dangerous—using the cannabinoid knowledge he had developed keeping Bentley alive. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD on an ongoing basis. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits of cannabis that Colin first discovered through his efforts to save Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

From Houston to Grady County: Why Our Story Matters Here

ABC13 KTRK Houston—Houston’s number-one news source—featured Colin and OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter during the same period. The media record documents a consistent pattern: when ABC13 needed to explain a new cannabis product, it called Colin. When a state agency reversed course on Delta-8 legality overnight, it called Colin. When a sitting president announced marijuana pardons, it called Colin.

Colin’s quote from the first ABC13 feature in September 2019 captures the OilWell philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). The company has been operating since 2019, generates approximately one million dollars in annual revenue, maintains a near-5.0 Google rating, and is Texas DSHS licensed. OilWell’s products are not mass-produced—they are carefully crafted with a personal touch, from the artwork on the packaging to the formulations inside. All artwork, formulations, and packaging are created in-house in Houston, using only OilWell’s own recipes and ideas. Colin brings Houston grit, McAllen roots, and a builder’s mindset to the company, but the posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

The OilWell RSO Philosophy: Built for Real People in Real Places Like Grady County

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in ways that are deliberate, evidence-motivated, and designed to solve the problems that limited Rick Simpson’s original vision.

Four core principles define OilWell’s approach, each aligning with and evolving Simpson’s original ethos:

1. Accessibility over gatekeeping. No medical card is required. Anyone age twenty-one or older can purchase. OilWell ships nationwide across the United States and internationally to customers who verify local legality. For Grady County residents who don’t have access to Atlanta dispensaries or who can’t drive three hours to the nearest licensed facility, this matters. Simpson believed medicine should be accessible to everyone; OilWell built a product and distribution model that makes that accessible legally.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. For Grady County residents who work in agriculture, manufacturing, or need to drive their kids to Cairo High School, this means you can use the product during the day without impairment. Simpson believed patients should control their own medicine; OilWell engineered a product that puts that control in your hands through chemistry.

3. Open-source formulas. OilWell publishes our complete formulas publicly—every cannabinoid, every milligram amount, every percentage—so that anyone who cannot afford the product can source ingredients and make their own version. For families in Grady County facing economic challenges, this isn’t just marketing. It’s a promise: if you can’t afford $129.99, you still have access to the recipe. Simpson gave his oil away for free and taught people how to make it; OilWell adapted that ethos for the modern cannabinoid marketplace.

4. Evidence-informed, not evidence-overstating. The science section in this document represents OilWell’s commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; OilWell has that access and uses it to distinguish between what is well-supported, what is emerging, and what is overstated.

Georgia Legal Framework: What Grady County Residents Need to Know

Georgia’s hemp law (House Bill 213, the Georgia Hemp Farming Act) aligns with the 2018 Farm Bill, legalizing hemp and hemp-derived products containing less than 0.3 percent delta-9 THC by dry weight. This is the foundation of OilWell’s RSO product design for Georgia customers.

The Georgia Low-THC Oil Registry allows registered patients with specific qualifying conditions to access cannabis oil containing up to 5% THC. However, the program is extremely limited—only about 15,000 Georgians are registered statewide, and there are only a handful of dispensaries, mostly in Atlanta. For the vast majority of Grady County residents, accessing the state’s medical program means a 3-4 hour drive, expensive doctor visits, and strict qualification requirements.

OilWell’s RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3 percent threshold. All cannabinoids are hemp-derived. The product is legal under Georgia law and can be shipped directly to your door in Grady County without a medical card.

THCa—tetrahydrocannabinolic acid—is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

Here’s what this means practically for Grady County residents: You can legally purchase, possess, and use OilWell’s RSO in Cairo, Whigham, or anywhere in Grady County. You can decarboxylate the THCa at home by heating the oil at 260°F for 45-60 minutes, converting 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams, this produces approximately 1,405 milligrams of total delta-9 THC—giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Important legal notice for Georgia customers: THCa converts to delta-9 THC when heated. Georgia law prohibits possession of cannabis products exceeding 0.3% delta-9 THC unless you are on the state registry. Do not decarboxylate the product unless you are legally authorized to possess higher-THC cannabis products in Georgia. OilWell ships with full documentation, Certificates of Analysis, and receipts. Customers are responsible for understanding and complying with Georgia law.

Open-Source Formulas: Why OilWell Publishes Everything

OilWell publishes our complete RSO formulas publicly—every cannabinoid, every milligram amount, every percentage. The RSO Sublingual Oil formula and RSO Vape Cartridge formula are detailed in full in this document. If someone in Grady County cannot afford OilWell’s products—$129.99 for the sublingual oil, $49.99 for the vape cartridge—they can see exactly what the formula contains, source the individual cannabinoid distillates and isolates, and make their own version.

This is a direct echo of Rick Simpson’s original ethos. Simpson gave his oil away for free and taught people how to make it. He never patented his method. He never charged patients. OilWell adapted that ethos for the modern cannabinoid marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa into delta-9 THC, leaving the patient with no choice about psychoactivity.

OilWell’s sublingual formula contains 1,500 milligrams of THCa in its acidic, non-psychoactive form. This creates three distinct usage options for Grady County customers:

Option 1—Raw, no heat. All 1,500 milligrams stays as THCa—completely non-psychoactive. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism. This option is compatible with work, driving, and daytime use with zero psychoactive impairment—perfect for Grady County residents who need to operate farm equipment, commute to Thomasville or Tallahassee, or stay sharp for family responsibilities.

Option 2—Fully activated, home decarboxylation. Heating the oil at 260°F for 45-60 minutes converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams, this yields approximately 1,405 milligrams of total delta-9 THC. Combined with 6,000 milligrams of delta-8 THC, the activated product achieves psychoactive potency comparable to traditional high-THC RSO—100 percent legally, because decarboxylation occurs at the customer’s discretion after purchase.

Option 3—Vape, auto-decarboxylation. The RSO Vape Cartridge vaporizes at 400-450°F, which instantly converts THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available.

The conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 milligram THCa = 0.877 milligrams delta-9 THC after decarboxylation.

This design puts the potency decision entirely in Grady County customers’ hands—aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry.

Solvent-Free Production

OilWell’s RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents are present in the finished product.

The product uses organic MCT oil as the carrier base—a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile. This is a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis are available on request and accessible through the OilWell website.

The Broader OilWell Product Portfolio

Beyond RSO, OilWell Cannabis produces products that reflect the formulation knowledge Colin built over Bentley’s ten-year journey:

Asshole Peach—OilWell’s most popular product. A carefully formulated experience designed to provide euphoric, long-lasting sensation. Particularly favored by veterans for its ability to relieve pain and PTSD symptoms.

Peace Gummies—Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. Peace Gummies helped him quit Xanax cold turkey. The formula is also available in a vape form for quick relief—Colin personally uses the vape to manage his insomnia and severe PTSD.

Custom creations—OilWell offers custom-made products tailored to specific needs. Whether it involves specific cannabinoid ratios, particular delivery formats, or formulations for unique health circumstances, OilWell designs targeted products on request. This includes formulations for vegans, diabetics, and those with specific dietary or health needs.

Two Product Formats: Which One Fits Your Grady County Life?

OilWell offers the RSO formula in two delivery formats, each designed for different use cases:

RSO Sublingual Oil—$129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15 to 45 minutes
• Duration: 4 to 6 hours
• Approximately 40-60 doses per bottle

RSO Vape Cartridge—$49.99

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual formula
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1 to 2 minutes (fastest delivery)
• Duration: 2 to 4 hours
• Automatic THCa decarboxylation at vaping temperature

When to use each format in Grady County:

How OilWell Compares: The Real Numbers

OilWell RSO vs. Georgia’s Medical Cannabis Program

For Grady County residents facing a 3-4 hour drive to Atlanta for Georgia’s limited program, OilWell offers legal access without the barriers.

OilWell RSO vs. Traditional Illegal RSO

Condition-Specific Usage Context for Grady County Residents

Important disclaimer: The following usage contexts are informed by cannabinoid research and OilWell’s formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Individual results may vary.

Chemotherapy-related nausea and appetite support

• Pre-chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2 to 3 vape puffs for immediate relief
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0 to 2.0 mL sublingual before bed (delivers 25-50 mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic pain (fibromyalgia, arthritis, neuropathy, agricultural injuries)

• Daytime: 0.3 to 0.5 mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep support for Grady County’s shift workers and retirees

• Before bed: 1.0 to 2.0 mL sublingual
• At 2.0 mL, this delivers 50 mg CBN—the dosage level investigated in 2024 sleep literature
• At 1.0 mL, this delivers 25 mg CBN—above the 20 mg threshold associated with reduced sleep disturbance
• Evidence: CBN sleep evidence [16][17]

Anxiety and stress

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual—full cannabinoid profile including CBN
• Evidence: CBD anxiety evidence [3], CBG pharmacology [7][8]

General titration principle: Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery to Grady County: How to Get OilWell RSO

OilWell ships nationwide to Georgia and directly to Grady County. Here’s what you need to know:

Shipping to Grady County:

• Delivery via USPS Priority Mail (2-3 business days) or FedEx/UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Georgia’s hot summers
• Signature-required option available
• Shipping cost: $10-15 for standard delivery

Georgia-specific shipping notes:

• All packages include full documentation and Certificates of Analysis required by Georgia law
• OilWell verifies age (21+) upon purchase
• Georgia’s hemp law permits shipment of Farm Bill-compliant products directly to consumers
• No medical card or state registration required

International access note: While this section focuses on Grady County, Georgia, it’s worth noting that OilWell’s THCa legal framework also enables international shipping to jurisdictions where hemp-derived products are permitted. The same product that ships to Cairo, Georgia can ship to Sydney, Australia or Berlin, Germany—completing a piece of Rick Simpson’s vision that prohibition made impossible during his lifetime.

How to Order:

• Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
• Phone: (832) 416-2816
• Email: [email protected]
• Instagram: @oilwellcbd

Media Recognition: Why Grady County Can Trust OilWell

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter.

Key moments from the media record:

• September 2019: First feature on CBD boom—Colin’s foundational quote about not selling snake oil
• May 2021: Steve Campion’s Delta-8 investigation—Colin’s iconic “Maybe you want to get high” honesty
• August 2021: $35,000 in product donated to encourage COVID vaccination—community health leadership
• October 2021: Proactive removal of Delta-8 products before enforcement—ethical business during crisis
• October 2022: Revelation of Colin’s personal marijuana conviction—authenticity and personal stakes
• April 2023: “Renaissance” framing—positioning at the frontier of legal cannabis

The complete media record demonstrates consistency across years, breadth of expertise, community action, personal stakes, and evolution of language. These features are not marketing materials. They are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as the most credible voice in Houston’s legal cannabis industry. That is the kind of recognition that cannot be purchased—it can only be earned.

The Complete Science: Every Cannabinoid and Terpene Explained

OilWell’s commitment to Grady County includes complete transparency about what the science actually says. Here’s the evidence profile for every compound in our formulas:

CBD (4,500mg in sublingual oil)

• Strongest human evidence in seizure disorders (Epidiolex approval)
• 2024 meta-analysis showed significant anxiolytic signal but limited clinical samples [3]
• 2024 pain review concluded promising but heterogeneous evidence [4]
• 2023 sleep review found methodologically weak literature [5]
• 2023 liver safety review found real signal for enzyme elevation [6]
• Bottom line: Most evidence-developed non-intoxicating cannabinoid, but concentrated in specific indications

CBG (3,000mg)

• Mostly review-level and preclinical; human evidence sparse [7][8]
• Pharmacology includes CB receptors, alpha-2 adrenoceptors, 5-HT1A
• Discussed for neurologic disorders, IBD, antibacterial activity
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8]

Delta-8 THC (6,000mg)

• Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 [9]
• 2022 review: similar PK/PD to delta-9, partial CB1 agonist, less potent [9]
• 2023 scoping review: dominated by animal studies, product chemistry, public health concerns [10]
• Manufacturing quality concerns noted [11]
• Bottom line: Psychoactive THC analogue with incomplete safety profile [9]-[11]

THCa (1,500mg)

• Acidic precursor, non-psychoactive unless heated [12]
• 2024 review: anti-inflammatory, immunomodulatory, neuroprotective possibilities in preclinical models [12]
• Bottom line: Highly relevant precursor; interpretation depends on processing/storage [12]

Delta-9 THC (90mg total)

• Strongest human evidence among psychoactive cannabinoids [1][13]-[15]
• FDA-approved for chemo nausea, HIV/AIDS appetite, some MS/pain outcomes [1]
• 2022 pain review: high-THC products may provide short-term benefit but increase dizziness, sedation, discontinuation [13]
• 2025 mental health review: high-concentration THC associated with psychosis, schizophrenia, CUD [15]
• Bottom line: Legitimate therapeutic relevance but clearest intoxication and safety liabilities [1][13]-[15]

CBN (750mg)

• Reputation for sleep exceeds evidence base [12][16][17]
• 2021 review: no clinical trials using validated sleep measures [16]
• 2024 sleep review: need for better-designed trials remains substantial [17]
• Bottom line: Cultural reputation stronger than clinical evidence [16][17]

CBC (750mg)

• Emerging, intriguing, overwhelmingly preclinical [18][19]
• 2024 review: distinct pharmacodynamics, antinociceptive, antibacterial, anti-seizure potential [18]
• Bottom line: Scientifically credible minor cannabinoid deserving more research [18][19]

Terpene Profile (5% in both products)

Limonene: Multifunctional monoterpene with antioxidant, anti-inflammatory properties in preclinical literature [21]; oxidation products are contact allergens [22]

Myrcene: Preclinical anxiolytic, anti-inflammatory, analgesic properties; human studies lacking [23]

Caryophyllene: Selective CB2 receptor agonist—most mechanistically interesting terpene [24]; anti-inflammatory, immunomodulatory potential

Pinene: Preclinical antioxidant, anti-inflammatory, neuroprotective signals; human clinical confirmation lacking [25]

Linalool: Discussed for stress/mood; preclinical neurological relevance; oxidation products are allergens [22][25][26]

Humulene: Preclinical anti-inflammatory; some rodent cannabimimetic properties [27]

Terpinolene: Least clinically characterized; evidence base dominated by in silico and animal studies [28]

Entourage Effect: The 2024 comprehensive review notes that robust proof of clinically meaningful entourage effects in humans remains limited [20][29]. Terpene bioactivity is plausible but not proven.

Research limits and interpretation for Grady County readers:

• Evidence base is highly uneven
• Different data types (extract, molecule, synthetic, terpene) are not interchangeable
• Minor cannabinoids are commercially interesting because underexplored—claims often inflated
• Product quality matters as much as molecule identity
• THCa chemistry changes with heating/storage

Common overstatements we avoid:

• CBN is NOT a clinically proven sleep aid
• Myrcene does NOT have proven human sedative effects
• Terpenes do NOT have proven entourage effects in humans
• THCa is NOT always non-psychoactive (heating converts it)
• Delta-8 THC is NOT safe because it’s hemp-derived (it’s psychoactive with incomplete safety data)

The Complete Formulas: Transparency You Can Verify

RSO Sublingual Oil ($129.99)

• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• 30mL bottle
• 553mg active cannabinoids per mL
• Organic MCT oil base
• Graduated dropper (0.1mL increments)

RSO Vape Cartridge ($49.99)

• Live terpenes: 5%+
• 1 gram cartridge
• 510-thread battery compatible
• Instant THCa decarboxylation at vape temperature

How to Order in Grady County

Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
Phone: (832) 416-2816
Email: [email protected]
Instagram: @oilwellcbd

Shipping to Grady County typically takes 2-3 business days via USPS Priority Mail. All packages are discreet and include required documentation for Georgia compliance.

Safety, Legal, and Medical Disclaimers for Georgia

Age requirement: 21+ years old to purchase RSO products.

Legal compliance: All OilWell products contain less than 0.3% delta-9 THC by dry weight and are Farm Bill compliant. Georgia’s hemp law permits possession and use of these products by adults. Customers are responsible for compliance with Georgia law, including the prohibition on decarboxylation unless properly authorized.

FDA disclaimer: These products have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease. The statements in this document have not been evaluated by the FDA. Individual results may vary.

Medical disclaimer: Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications (particularly blood thinners, anti-seizure medications, or other drugs metabolized by the liver), are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Do not use if you are subject to drug testing for employment or legal reasons, as delta-8 THC and decarboxylated THCa will trigger positive results.

Safety warnings: May cause drowsiness or impairment. Do not consume with alcohol. Keep out of reach of children and pets. Store in a cool, dark place. Use caution when heating for decarboxylation—use oven-safe glass only and avoid open flames due to flammability of MCT oil vapors.

Warning for Georgia medical cannabis patients: If you are registered with Georgia’s Low-THC Oil Registry, consult your physician before using OilWell products. Do not combine with state-issued oil without medical supervision, as total THC exposure may exceed Georgia’s 5% cap.

Limited warranty: OilWell guarantees product quality and accurate labeling as verified by third-party lab testing. No warranty is made regarding therapeutic outcomes. Customer assumes all legal responsibility for possession and use in their jurisdiction.

Returns: Unopened products may be returned within 30 days. Opened products are non-returnable due to safety and contamination concerns.

Contact for Georgia customers: For questions about Georgia law, shipping to Grady County, or product selection, call (832) 416-2816 or email [email protected].

The Complete Reference List

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ)—Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Final Word for Grady County

Rick Simpson started with a simple idea: people suffering from cancer and chronic pain deserved access to concentrated cannabis oil. He gave it away for free, taught people how to make it, and sparked a global movement. But he operated in a time before legalization, before lab testing, before we understood cannabinoid pharmacology the way we do now.

OilWell Cannabis stands on that foundation but builds with modern tools: solvent-free production, third-party lab testing, seven defined cannabinoids, preserved terpenes, and the THCa innovation that lets Grady County residents choose their own potency level within the law. We publish our formulas because Simpson taught us that medicine should be accessible. We cite the evidence because you deserve to know what the science actually says. We share Colin’s personal story—from the borderlands of McAllen to Bentley’s recovery to his own benzo withdrawal—because you deserve to know who you’re buying from.

This is not traditional RSO. It’s something better for 2025: honest, legal, precise, and accessible to everyone in Grady County who needs it. Whether you’re dealing with cancer, chronic pain from years of farm work, PTSD from military service, or the insomnia that comes with life’s stresses, we hope this guide gives you the information to make an informed decision.

As Colin said in that first ABC13 interview back in 2019: we’re not trying to sell you snake oil or hope. We’re trying to give you the best possible version of the information so you can give it a fair shot and decide if it’s right or wrong for you. That’s what every person in Grady County deserves.

Order today at https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/ or call (832) 416-2816 with questions.

Free delivery to the Texas Medical Center. $10-15 shipping to Grady County, Georgia. Ships within 24 hours.